New Research on Imaging Technology for Cancer Therapy-Related Cardiovascular Toxicity

A recent study by researchers from the First Affiliated Hospital of Nanjing Medical University has highlighted the importance of noninvasive imaging technologies in the early diagnosis and monitoring of cancer therapy-related cardiovascular toxicity (CTR-CVT) in tumor patients. According to the research, cardiovascular damage caused by cancer treatment has become a significant cause of death among tumor survivors, and the field of cardio-oncology requires systematic guidance documents on the application of imaging techniques in clinical practice. In response, a group of experts from the Chinese Anti-Cancer Association Society of Integrative Cardio-oncology, the Ultrasound Branch of the Chinese Medical Association, and the Chinese Society of Echocardiography have formulated the "Chinese guideline for the clinical application of noninvasive imaging technology in accessing cancer therapy-related cardiovascular toxicity."

Key Takeaways:

• The study emphasizes the critical role of noninvasive imaging technologies in the early diagnosis and monitoring of CTR-CVT, which has become a significant cause of death among tumor survivors.
• The researchers highlight the lack of systematic guidance documents on the application of imaging techniques in cardio-oncology and the need for a standardized approach to diagnosis and treatment.
• The Chinese guideline proposes noninvasive imaging examination methods and monitoring strategies for CTR-CVT, aiming to standardize and guide clinical practice for multidisciplinary physicians specializing in cardio-oncology in China.
• The research is based on a systematic evaluation of guidelines and evidence-based medical research in the field of cardio-oncology domestically and abroad, as well as data derived from evidence-based medical research in China.
• The study involves experts from the Chinese Anti-Cancer Association Society of Integrative Cardio-oncology, the Ultrasound Branch of the Chinese Medical Association, and the Chinese Society of Echocardiography.

Statistics:

• Cancer therapy-related cardiovascular toxicity (CTR-CVT) accounts for a significant proportion of deaths among tumor survivors, highlighting the need for effective diagnosis and treatment strategies.
• The study emphasizes the importance of noninvasive imaging technologies, which are crucial for early diagnosis and monitoring of CTR-CVT.
• The Chinese guideline proposes specific noninvasive imaging examination methods and monitoring strategies for CTR-CVT, aiming to standardize clinical practice in China.

Sources:

• Chinese guideline for the clinical application of noninvasive imaging technology in accessing cancer therapy-related cardiovascular toxicity. Journal of Geriatric Cardiology, 2025;22(5):477-496.
• Tsinghua Univ Press, B605D, Xue Yan Building, Beijing, 100084, Peoples R China
• Journal of Geriatric Cardiology can be contacted at: Tsinghua Univ Press, B605D, Xue Yan Building, Beijing, 100084, Peoples R China.